Evolving Health Care for the Next Pandemic

April 23, 2020

By Grant M. Gallagher

Video

Stephen Klasko, MD, MBA, CEO of Thomas Jefferson University Hospitals, discusses what COVID-19 has taught hospitals about preparing for pandemics.

Segment Description: Stephen Klasko, MD, MBA, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses what COVID-19 has taught hospitals about preparing for pandemics.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Recent Videos

Related Content

In People With Cancer, COVID-19 Vaccine Boosters Reduce Hospitalizations

In People With Cancer, COVID-19 Vaccine Boosters Reduce Hospitalizations

Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing

Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc

FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years

FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years

A Passion for Infectious Disease Education and Communication

A Passion for Infectious Disease Education and Communication

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD;Timothy Gauthier, PharmD, BCPS, BCIDP

Structural Barriers Drive Racial Disparities in Outpatient COVID-19 Treatment

Structural Barriers Drive Racial Disparities in Outpatient COVID-19 Treatment

The group includes Michael Peluso, MD, MHS; Amy Proal, PhD; and David Putrino, PhD, and will study monoclonal antibody therapies targeting persistent spike protein.

Invivyd Forms SPEAR Study Group to Investigate Pemivibart for Long COVID and Post-Vaccination Syndrome

Related Content

In People With Cancer, COVID-19 Vaccine Boosters Reduce Hospitalizations

In People With Cancer, COVID-19 Vaccine Boosters Reduce Hospitalizations

Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing

Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc

FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years

FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years

A Passion for Infectious Disease Education and Communication

A Passion for Infectious Disease Education and Communication

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD;Timothy Gauthier, PharmD, BCPS, BCIDP

Structural Barriers Drive Racial Disparities in Outpatient COVID-19 Treatment

Structural Barriers Drive Racial Disparities in Outpatient COVID-19 Treatment

The group includes Michael Peluso, MD, MHS; Amy Proal, PhD; and David Putrino, PhD, and will study monoclonal antibody therapies targeting persistent spike protein.

Invivyd Forms SPEAR Study Group to Investigate Pemivibart for Long COVID and Post-Vaccination Syndrome

Contagion, Summer 2025 Digital Edition

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.